Dual immunofluorescence labeling with cell-specific markers localizes BRCA1 in both basal and luminal epithelial cells in primary outgrowth from noncancerous mammary ductal and alveolar preparations

Cell and Tissue Research

Volumn 298, Issue 3, 1999, Pages 481-487

  Daniel, Dianne C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Breast; Cytokeratin; Human; Organoid; Tumor suppressor

Indexed keywords

BRCA1 PROTEIN; CELL MARKER; CYTOKERATIN 19; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; VIMENTIN;

ARTICLE; BASAL CELL; BREAST CANCER; BREAST DUCT; CANCER GROWTH; CELL NUCLEUS; CELL SPECIFICITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTERPHASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING; TUMOR SUPPRESSOR GENE;

BIOLOGICAL MARKERS; BRCA1 PROTEIN; BREAST; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINS; MAMMAPLASTY; RECEPTOR, ERBB-2; VIMENTIN;

EID: 0032755967     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050070     Document Type: Article

References (30)

1. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK, Lee WH (1995) Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789-91
2. Chen Y, Chen P-L, Riley DJ, Lee W-H, Allred DC, Osborne CK (1996a) Location of BRCA1 in human breast and ovarian cancer cells. Technical Comments. Science 272:125-126
3. Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH (1996b) BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56:3168-72
4. Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH ( 1996c) The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem 271:32863-8
5. Easton DF, Bishop DT, Ford D, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 52:678-701
6. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334:143-9
7. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-2
8. Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ 3rd, Cowan KH ( 1996) Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 7:717-23
9. Hammond SL, Ham RG, Stampfer MR (1984) Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81:5435-9
10. Kinzler KW, Vogelstein B (1997) Cancer-susceptibility genes. Gatekeepers and caretakers (New, Views). Nature 386:761, 763
11. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334:137-42
12. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 9:439-43
13. Parkes HC, Lillycrop K, Howell A, Craig RK (1990) C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis. Br J Cancer 61:39-45
14. Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA, Preisler HD (1992) c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res 52:2597-602
15. Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5:953-62
16. Rao VN, Shao N, Ahmad M, Reddy ES (1996) Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12:523-8
17. Ruffner H, Verma IM (1997) BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci USA 94:7138-43
18. Scully R, Ganesan S, Brown M, DeCaprio JA, Cannistra SA, Feunteun J, Schnitt S, Livingston DM (1996) Location of BRCA1 in human breast and ovarian cancer cells. Technical comments. Science 272:123-125
19. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM (1997a) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-75
20. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM (1997b) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425-35
21. Stampfer M (1985) Isolation and growth of human mammary epithelial cells. J Tissue Cult Methods 9:107-115
22. Stampfer M, Hallowes RC, Hackett AJ (1980) Growth of normal human mammary cells in culture. In Vitro 16:415-25
23. Taylor-Papadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM (1989) Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci 94:403-13
24. Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP, Polakis P (1996) Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 271:28630-5
25. Thomas JE, Smith M, Tonkinson JL, Rubinfeld B, Polakis P (1997) Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ 8:801-9
26. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9:444-50
27. Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA, Marks JR (1996) BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7:711-5
28. Vijver MJ van de , Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R (1988) Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319:1239-45
29. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230-4
30. Zhang HT, Zhang X, Zhao HZ, Kajino Y, Weber BL, Davis JG, Wang Q, O'Rourke DM, Zhang HB, Kajino K, Greene MI (1997) Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14:2863-9